Clinical Trial: Carbon Ion Radiotherapy with or without PARP Inhibitor for Skull Base/Sacral Chordoma: A Multicenter, Randomized, Open-Label, Phase II Prospective Clinical Trial (China)

China, Sept. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Carbon Ion Radiotherapy with or without PARP Inhibitor for Skull Base/Sacral Chordoma: A Multicenter, Randomized, Open-Label, Phase II Prospective Clinical Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132229

Registration Time: 2026/09/10

Type: Interventional study

Primary Sponsor: The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342675

Published by HT Digital Content Services with permission from Health Daily Digest....